Chemotherapy-Free Combo Improves Survival in Metastatic Colorectal Cancer

(MedPage Today) — BERLIN — The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly improved overall survival (OS) among previously treated patients with metastatic colorectal cancer, a phase…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118047

Author :

Publish date : 2025-10-20 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Chemotherapy-Free Combo Improves Survival in Metastatic Colorectal Cancer

Primary Care Docs Spend This Many Hours Per Week Caring for Patients

Global Study Reports Rise in Several Cancers Among Adults of All Ages

Related Posts

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Research Asks Whether Fitness Apps Do More Harm Than Good

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Rising LATE Dementia Diagnoses; Wooden Neurons; Remyelination Trial Fails

Doctors Have a Front-Row Seat to the Caregiver Crisis

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Research Asks Whether Fitness Apps Do More Harm Than Good

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Rising LATE Dementia Diagnoses; Wooden Neurons; Remyelination Trial Fails

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Categories

Archives